National Institute of Neurological Disorders and Stroke Notice of Meeting, 12859-12860 [2012-5037]

Download as PDF Federal Register / Vol. 77, No. 42 / Friday, March 2, 2012 / Notices Time: 10 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Jose H Guerrier, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5218, MSC 7852, Bethesda, MD 20892, 301–435– 1137, guerriej@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Small Business: Digestive Sciences. Date: March 26, 2012. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Bonnie L. Burgess-Beusse, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2182, MSC 7818, Bethesda, MD 20892, 301–435– 1783, beusseb@mail.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Pilot and Feasibility Clinical Research Studies in Digestive Diseases and Nurtrition Date: March 26, 2012. Time: 2 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Peter J Perrin, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2180, MSC 7818, Bethesda, MD 20892, (301) 435– 0682, perrinp@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) National Institute of Neurological Disorders and Stroke Notice of Meeting The meeting will feature invited speakers and discussion of committee business items including a report on the findings of the Institute of Medicine report Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research and a review of information gathered on federally-funded pain research. The meeting will be open to the public and accessible by live webcast and conference call. Name of Committee: Interagency Pain Research Coordinating Committee. Type of meeting: Open Meeting. Date: March 27, 2012. Time: 8:30 a.m. to 4:30 p.m. *Eastern Time*—Approximate end time. Agenda: The meeting will feature invited speakers and discussion of committee business items including a report on the findings of the Institute of Medicine report Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research and a review of information gathered on federally-funded pain research. Place: National Institutes of Health, Building 1, Wilson Hall, 1 Center Drive, Bethesda, MD 20892. Conference Call: Dial: 800–779–1482, Participant Passcode: 31855. Cost: The meeting is free and open to the public. Webcast Live https://videocast.nih. gov/. Registration: https://iprcc.nih.gov/. Pre-registration is recommended to expedite check-in. Seating in the meeting room is limited to room capacity and is on a first come, first served basis. Deadlines: Notification of intent to present oral comments: Friday, March 16, 2012, by 5 p.m. ET Submission of written/electronic statement for oral comments: Tuesday, March 20, 2012, by 5 p.m. ET Submission of written comments: Thursday, March 22, 2012, by 5 p.m. ET Access: Medical Center Metro (Red Line) Visitor Information: https:// www.nih.gov/about/visitor/index.htm. Contact Person: Dr. Paul Scott, Director, Office of Science Policy and Planning, National Institute of Neurological Disorders and Stroke, NIH, 31 Center Drive, Room 8A03, Bethesda, MD 20892, Phone: (301) 496–9271, Email: IPRCC PublicInquiries@mail.nih.gov. Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of an Interagency Pain Research Coordinating Committee (IPRCC) meeting. Please Note: Any member of the public interested in presenting oral comments to the Committee must notify the Contact Person listed on this notice by 5 p.m. ET on Friday, March 16, 2012, with their request to present oral comments at the meeting. Interested individuals and representatives of Dated: February 24, 2012. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2012–5046 Filed 3–1–12; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES tkelley on DSK3SPTVN1PROD with NOTICES National Institutes of Health VerDate Mar<15>2010 18:58 Mar 01, 2012 Jkt 226001 PO 00000 Frm 00068 Fmt 4703 Sfmt 4703 12859 organizations must submit a written/ electronic copy of the oral statement/ comments including a brief description of the organization represented by 5 p.m. ET on Tuesday, March 20, 2012. Statements submitted will become a part of the public record. Only one representative of an organization will be allowed to present oral comments on behalf of that organization, and presentations will be limited to three to five minutes per speaker, depending on number of speakers to be accommodated within the allotted time. Speakers will be assigned a time to speak in the order of the date and time when their request to speak is received, along with the required submission of the written/ electronic statement by the specified deadline. If special accommodations are needed, please email the Contact Person listed above. In addition, any interested person may submit written comments to the IPRCC prior to the meeting by sending the comments to the Contact Person listed on this notice by 5 p.m. ET, Thursday, March 22, 2012. The comments should include the name and, when applicable, the business or professional affiliation of the interested person. All written comments received by the deadlines for both oral and written public comments will be provided to the IPRCC for their consideration and will become part of the public record. The meeting will be open to the public through a conference call phone number and webcast live on the Internet. Members of the public who participate using the conference call phone number will be able to listen to the meeting but will not be heard. If you experience any technical problems with the conference call or webcast, please call Operator Service on 301 496–4517 for conference call issues and the NIH IT Service Desk at (301) 496–4357, toll free (866) 319–4357, for webcast issues. Individuals who participate in person or by using these electronic services and who need special assistance, such as captioning of the conference call or other reasonable accommodations, should submit a request to the Contact Person listed on this notice at least seven days prior to the meeting. As a part of security procedures, attendees should be prepared to present a photo ID during the security process to get on the NIH campus. For a full description, please see: https:// www.nih.gov/about/visitorsecurity.htm. Pre-registration is recommended. Seating will be limited to the room capacity and seats will be on a first come, first served basis, with expedited check-in for those who are preregistered. E:\FR\FM\02MRN1.SGM 02MRN1 12860 Federal Register / Vol. 77, No. 42 / Friday, March 2, 2012 / Notices Information about the IPRCC is available on the Web site: https:// iprcc.nih.gov/. DEPARTMENT OF HEALTH AND HUMAN SERVICES Dated: February 24, 2012. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy . National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting [FR Doc. 2012–5037 Filed 3–1–12; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meetings tkelley on DSK3SPTVN1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel, Autism Centers of Excellence: Centers. Date: March 28–29, 2012. Time: 7:30 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Cathy J. Wedeen, Ph.D., Scientific Review Officer, Division of Scientific Review, OD, Eunice Kennedy Shriver National Institute of Child Health And Human Development, NIH, 6100 Executive Blvd., Room 5B01–G, Bethesda, MD 20892, 301–435–6878, wedeenc@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) Dated: February 24, 2012. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2012–5031 Filed 3–1–12; 8:45 am] BILLING CODE 4140–01–P VerDate Mar<15>2010 17:01 Mar 01, 2012 Jkt 226001 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the Board of Scientific Counselors, NIDDK. The meeting will be closed to the public as indicated below in accordance with the provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended for the review, discussion, and evaluation of individual intramural programs and projects conducted by the NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES, including consideration of personnel qualifications and performance, and the competence of individual investigators, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Board of Scientific Counselors, NIDDK. Date: April 5–6, 2012. Time: April 5, 2012, 8:30 a.m. to 3:15 p.m. Agenda: To review and evaluate personal qualifications and performance, and competence of individual investigators. Place: National Institutes of Health, Building 10, 10 Center Drive, Conference Room 9S235, Bethesda, MD 20892. Time: April 6, 2012, 8:30 a.m. to 3:15 p.m. Agenda: To review and evaluate personal qualifications and performance, and competence of individual investigators. Place: National Institutes of Health, Building 10, 10 Center Drive, Conference Room 9S235, Bethesda, MD 20892. Contact Person: James E. Balow, MD, Clinical Director, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Building 10, Room 9N222, Bethesda, MD 20892–1818, 301–496–4181, jimb@mail.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; PO 00000 Frm 00069 Fmt 4703 Sfmt 4703 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) Dated: February 24, 2012. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2012–5018 Filed 3–1–12; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel, Maternal and Child Health in Poor Countries: Evidence from Randomized Evaluations MIT. Date: March 19, 2012. Time: 2 p.m. to 3:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6100 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Carla T. Walls, Ph.D., Scientific Review Officer, Division of Scientific Review, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, 6100 Executive Boulevard, Room 5B01, Bethesda, MD 20892–7510, 301–435–6898, wallsc@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) E:\FR\FM\02MRN1.SGM 02MRN1

Agencies

[Federal Register Volume 77, Number 42 (Friday, March 2, 2012)]
[Notices]
[Pages 12859-12860]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-5037]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke Notice of 
Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of an Interagency Pain 
Research Coordinating Committee (IPRCC) meeting.
    The meeting will feature invited speakers and discussion of 
committee business items including a report on the findings of the 
Institute of Medicine report Relieving Pain in America: A Blueprint for 
Transforming Prevention, Care, Education, and Research and a review of 
information gathered on federally-funded pain research.
    The meeting will be open to the public and accessible by live 
webcast and conference call.
    Name of Committee: Interagency Pain Research Coordinating 
Committee.
    Type of meeting: Open Meeting.
    Date: March 27, 2012.
    Time: 8:30 a.m. to 4:30 p.m. *Eastern Time*--Approximate end time.
    Agenda: The meeting will feature invited speakers and discussion of 
committee business items including a report on the findings of the 
Institute of Medicine report Relieving Pain in America: A Blueprint for 
Transforming Prevention, Care, Education, and Research and a review of 
information gathered on federally-funded pain research.
    Place: National Institutes of Health, Building 1, Wilson Hall, 1 
Center Drive, Bethesda, MD 20892.
    Conference Call: Dial: 800-779-1482, Participant Passcode: 31855.
    Cost: The meeting is free and open to the public.
    Webcast Live https://videocast.nih.gov/ gov/.
    Registration: https://iprcc.nih.gov/. Pre-registration is 
recommended to expedite check-in. Seating in the meeting room is 
limited to room capacity and is on a first come, first served basis.
    Deadlines: Notification of intent to present oral comments: Friday, 
March 16, 2012, by 5 p.m. ET
    Submission of written/electronic statement for oral comments: 
Tuesday, March 20, 2012, by 5 p.m. ET
    Submission of written comments: Thursday, March 22, 2012, by 5 p.m. 
ET
    Access: Medical Center Metro (Red Line) Visitor Information: https://www.nih.gov/about/visitor/index.htm.
    Contact Person: Dr. Paul Scott, Director, Office of Science Policy 
and Planning, National Institute of Neurological Disorders and Stroke, 
NIH, 31 Center Drive, Room 8A03, Bethesda, MD 20892, Phone: (301) 496-
9271, Email: IPRCC PublicInquiries@mail.nih.gov.

    Please Note:  Any member of the public interested in presenting 
oral comments to the Committee must notify the Contact Person listed 
on this notice by 5 p.m. ET on Friday, March 16, 2012, with their 
request to present oral comments at the meeting. Interested 
individuals and representatives of organizations must submit a 
written/electronic copy of the oral statement/comments including a 
brief description of the organization represented by 5 p.m. ET on 
Tuesday, March 20, 2012.

    Statements submitted will become a part of the public record. Only 
one representative of an organization will be allowed to present oral 
comments on behalf of that organization, and presentations will be 
limited to three to five minutes per speaker, depending on number of 
speakers to be accommodated within the allotted time. Speakers will be 
assigned a time to speak in the order of the date and time when their 
request to speak is received, along with the required submission of the 
written/electronic statement by the specified deadline. If special 
accommodations are needed, please email the Contact Person listed 
above.
    In addition, any interested person may submit written comments to 
the IPRCC prior to the meeting by sending the comments to the Contact 
Person listed on this notice by 5 p.m. ET, Thursday, March 22, 2012. 
The comments should include the name and, when applicable, the business 
or professional affiliation of the interested person. All written 
comments received by the deadlines for both oral and written public 
comments will be provided to the IPRCC for their consideration and will 
become part of the public record. The meeting will be open to the 
public through a conference call phone number and webcast live on the 
Internet. Members of the public who participate using the conference 
call phone number will be able to listen to the meeting but will not be 
heard. If you experience any technical problems with the conference 
call or webcast, please call Operator Service on 301 496-4517 for 
conference call issues and the NIH IT Service Desk at (301) 496-4357, 
toll free (866) 319-4357, for webcast issues.
    Individuals who participate in person or by using these electronic 
services and who need special assistance, such as captioning of the 
conference call or other reasonable accommodations, should submit a 
request to the Contact Person listed on this notice at least seven days 
prior to the meeting.
    As a part of security procedures, attendees should be prepared to 
present a photo ID during the security process to get on the NIH 
campus. For a full description, please see: https://www.nih.gov/about/visitorsecurity.htm.
    Pre-registration is recommended. Seating will be limited to the 
room capacity and seats will be on a first come, first served basis, 
with expedited check-in for those who are pre-registered.

[[Page 12860]]

    Information about the IPRCC is available on the Web site: https://iprcc.nih.gov/.

    Dated: February 24, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy .
[FR Doc. 2012-5037 Filed 3-1-12; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.